Nu-Med Plus, Inc.
NUMD
$0.032
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -35.00% | -9.22% | -83.18% | 15.23% | -30.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.00% | -9.22% | -83.18% | 15.23% | -30.74% |
| Operating Income | 35.00% | 9.22% | 83.18% | -15.23% | 30.74% |
| Income Before Tax | 32.37% | 8.72% | 81.27% | -14.02% | 28.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.37% | 8.72% | 81.27% | -14.02% | 28.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.37% | 8.72% | 81.27% | -14.02% | 28.81% |
| EBIT | 35.00% | 9.22% | 83.18% | -15.23% | 30.74% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 50.00% | 33.33% | 85.71% | 0.00% | 33.33% |
| Normalized Basic EPS | 0.00% | 50.00% | 75.00% | 0.00% | 50.00% |
| EPS Diluted | 50.00% | 33.33% | 85.71% | 0.00% | 33.33% |
| Normalized Diluted EPS | 0.00% | 50.00% | 75.00% | 0.00% | 50.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 9.07% | 0.00% | 2.70% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 9.07% | 0.00% | 2.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |